LONDON, Dec. 1, 2021 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX) announced today that the intended use for its Food and Drug Administration (FDA) Emergency Use Authorization (EUA) SARS-CoV-2 RNA STAR ...
The chief executive and medical director of Fast Lab Technologies allegedly engaged in a $500 million fraud scheme involving COVID-19 tests, the U.S. Department of Justice (DOJ) said. Fast Lab CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results